---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-010035"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2025-03-12T23:59:59+00:00"
generated_at: "2026-05-24T22:32:17.988001+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BriaPro Therapeutics (2/3 owned by BriaCell) reports six-month net loss of $233K, cash only $1, going concern warning

## Summary
- Net loss for six months ended Jan 31, 2025: $233,185; accumulated deficit $673,394.
- Cash and cash equivalents only $1; total assets $192,161 mostly intangible patents.
- Current liabilities $658,049 due to related party (BriaCell); warrant liability $172,991.
- No revenue; R&D expenses $130,023, G&A $80,012 for six months.
- Going concern warning: material uncertainty about ability to raise capital to continue operations.

## SEC filing metadata
- accession: 0001493152-25-010035
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2025-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315225010035/0001493152-25-010035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315225010035/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-010035
- JSON: https://secwatch.observer/filing/0001493152-25-010035.json
- Plain text: https://secwatch.observer/filing/0001493152-25-010035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.